Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

Ryo Shimizu, Masahiro Takeuchi, Emiko Sakaida, Chikako Ohwada, Masako Toyosaki, Shinichiro Machida, Makoto Onizuka, Katsuhiro Shono, Masahiro Onoda, Takeshi Saito, Shingo Yano, Masatsugu Tanaka, Shin Fujisawa, Takehiko Mori, Kensuke Usuki, Satoshi Takahashi, Heiwa Kanamori, Chiaki Nakaseko, Shinichiro Okamoto

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1781-1783
Number of pages3
JournalAnnals of Hematology
Volume98
Issue number7
DOIs
Publication statusPublished - 2019 Jul 1

ASJC Scopus subject areas

  • Hematology

Cite this

Shimizu, R., Takeuchi, M., Sakaida, E., Ohwada, C., Toyosaki, M., Machida, S., Onizuka, M., Shono, K., Onoda, M., Saito, T., Yano, S., Tanaka, M., Fujisawa, S., Mori, T., Usuki, K., Takahashi, S., Kanamori, H., Nakaseko, C., & Okamoto, S. (2019). Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation. Annals of Hematology, 98(7), 1781-1783. https://doi.org/10.1007/s00277-019-03717-8